Matches in Wikidata for { <http://www.wikidata.org/entity/Q92373816> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q92373816 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92373816 description "scientific article published on 14 January 2020" @default.
- Q92373816 description "wetenschappelijk artikel" @default.
- Q92373816 description "наукова стаття, опублікована 14 січня 2020" @default.
- Q92373816 name "Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent" @default.
- Q92373816 name "Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent" @default.
- Q92373816 type Item @default.
- Q92373816 label "Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent" @default.
- Q92373816 label "Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent" @default.
- Q92373816 prefLabel "Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent" @default.
- Q92373816 prefLabel "Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent" @default.
- Q92373816 P1433 Q92373816-BCC29913-9D94-4626-9D64-F4AF50127B44 @default.
- Q92373816 P1476 Q92373816-DC3F4A62-A463-43CD-A98A-2BB41A822176 @default.
- Q92373816 P2093 Q92373816-13E85519-2016-4442-B759-828387C55724 @default.
- Q92373816 P2093 Q92373816-1F748BD0-9EEB-4E3C-82E6-8D5111284751 @default.
- Q92373816 P2093 Q92373816-204D33A6-016D-484E-9010-DB951B851A98 @default.
- Q92373816 P2093 Q92373816-271B134B-0E48-4BED-B315-3BA57F84A01B @default.
- Q92373816 P2093 Q92373816-310488D7-1841-4064-AEF5-042CDF115D74 @default.
- Q92373816 P2093 Q92373816-3585750E-6107-4585-B3A9-52698CD1B2D9 @default.
- Q92373816 P2093 Q92373816-3892D3E0-1457-4574-8D7D-5FCFDE55CB47 @default.
- Q92373816 P2093 Q92373816-4C473114-BBBE-4D55-9E19-A5DACEB95FCF @default.
- Q92373816 P2093 Q92373816-65C74F1E-1FB1-4C51-A3C8-1B8B629538FD @default.
- Q92373816 P2093 Q92373816-6BE4C704-40E6-4BAD-82EE-3E0243B57D9B @default.
- Q92373816 P2093 Q92373816-70F9BD57-D6F4-404E-98C4-6AEBA7DA8DAF @default.
- Q92373816 P2093 Q92373816-9BFA4AD3-54A9-4E8C-B13D-BD12B892CCE7 @default.
- Q92373816 P2093 Q92373816-CB6A0CDB-2709-426A-BE48-2FAC26D5D158 @default.
- Q92373816 P2093 Q92373816-E5A2D8FA-F1F3-4A8F-9D05-751DBE8E17FE @default.
- Q92373816 P2093 Q92373816-F39ECA8A-1D1A-4259-A20B-A0C5818400E7 @default.
- Q92373816 P304 Q92373816-612F3F86-3381-4FE7-B02D-636DEF17583C @default.
- Q92373816 P31 Q92373816-FFEFB496-2266-4C68-9AF3-EA21CBA6DB18 @default.
- Q92373816 P356 Q92373816-58271588-7332-402C-9960-78F30B6929DC @default.
- Q92373816 P433 Q92373816-499913C6-665A-42BE-BEBE-52B9E33D0CD5 @default.
- Q92373816 P478 Q92373816-717F8EC2-0B4B-4A23-B216-02B35584ADA7 @default.
- Q92373816 P50 Q92373816-5BCC9858-93AA-4A66-8053-556CD5726AFE @default.
- Q92373816 P50 Q92373816-FB287E52-2030-4CEA-B31A-D60B79588CC6 @default.
- Q92373816 P577 Q92373816-7D11A48E-5B27-4C0B-A7E1-1B64A004D15A @default.
- Q92373816 P698 Q92373816-3FD0BE08-29EC-4DE6-B336-BE65AA45DC93 @default.
- Q92373816 P356 ACS.JMEDCHEM.9B01427 @default.
- Q92373816 P698 31895562 @default.
- Q92373816 P1433 Q900316 @default.
- Q92373816 P1476 "Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent" @default.
- Q92373816 P2093 "Akihiro Ohashi" @default.
- Q92373816 P2093 "Hideto Hara" @default.
- Q92373816 P2093 "Isaac Hoffman" @default.
- Q92373816 P2093 "Kenichi Iwai" @default.
- Q92373816 P2093 "Kentaro Iwata" @default.
- Q92373816 P2093 "Misaki Homma" @default.
- Q92373816 P2093 "Momoko Ohori" @default.
- Q92373816 P2093 "Nobuo Cho" @default.
- Q92373816 P2093 "Noriko Uchiyama" @default.
- Q92373816 P2093 "Robert Skene" @default.
- Q92373816 P2093 "Takashi Imada" @default.
- Q92373816 P2093 "Tohru Miyazaki" @default.
- Q92373816 P2093 "Toshiyuki Nomura" @default.
- Q92373816 P2093 "Yukiko Yamamoto" @default.
- Q92373816 P2093 "Yuya Oguro" @default.
- Q92373816 P304 "1084-1104" @default.
- Q92373816 P31 Q13442814 @default.
- Q92373816 P356 "10.1021/ACS.JMEDCHEM.9B01427" @default.
- Q92373816 P433 "3" @default.
- Q92373816 P478 "63" @default.
- Q92373816 P50 Q58339197 @default.
- Q92373816 P50 Q91163334 @default.
- Q92373816 P577 "2020-01-14T00:00:00Z" @default.
- Q92373816 P698 "31895562" @default.